Experienced biotechnology entrepreneurs, distinguished scientists and a development team with a track record of success
Our Commitment to Data-driven Science
First to discover
The impact of disulfiram and azlocillin on persister bacteria in Lyme disease
A narrow-spectrum, selective, anti-spirochetal compound with limited impact on healthy gut microbiome
A distinct microbiome signature for patients with late-stage Lyme disease